This purposeful interaction between the serotoninergic and central dopaminergic methods has become demonstrated in experiments with haloperidol, a D2 receptor antagonist that attenuates the psychotomimetic outcomes of psilocybin [5]. Psilocybin that contains mushrooms: a speedily building biotechnology industry from the psychiatry, biomedical and nutraceutical fields In Tennessee, pos... https://entheogenicmushrooms82579.tblogz.com/magic-fungi-secrets-42253102